Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Norepinephrine for Orthostatic Hypotension
NCT01285908Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Jan 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of norepinephrine in orthostatic hypotension (OH), sponsored by National Institute of Neurological Disorders and Stroke. Started Jan 2011; status: completed.
02
Drugs
norepinephrine
03
Conditions
orthostatic hypotension (OH)
Beyond the preview
Go deeper on NCT01285908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01285908.